Category: Blog

Multi-Asset Class Total Return Since March 2020 Chart showing how the coronavirus and a COVID-19 vaccine affect asset returns. Image: Deutsche Bank

U.S. Fund Flows (YTD Cumulative) U.S. equity funds have seen inflows over the past few weeks, but there is still a lot of cash on the sideline. Image: Goldman Sachs Global Investment Research

Coronavirus – Proportion of Residents Planning to Be Vaccinated Against COVID-19 Within 3 Months of Vaccine Availability Will there be enough people in the world who will agree to be vaccinated to get rid of the coronavirus? Image: Deutsche Bank

Flow – U.S. Small Cap Stocks U.S. small cap stocks are soaring, as positive news on a COVID-19 vaccine has fueled optimism about an economic recovery next year. Image: BofA Global Investment Strategy

Small Cap Stocks – Russell 2000 Index as a % of Its 200-Day Moving Average Are investors too optimistic, as small-cap stocks are now very stretched? Image: BofA Global Research

Cyclical Stocks – World Cyclicals vs. Defensives Around Bear Markets Cyclicals have recovered vs. defensives, in line with the average recovery, but they have lagged the post-GFC recovery. Image: Goldman Sachs Global Investment Research

Performance – S&P 500 and Largest 20-Day Gains Ever Historically, past big 20-day rallies saw the S&P 500 higher 6- and 12-months later. Image: LPL Research

Value vs. Growth – S&P 500 Index Earnings-Per-Share Growth EPS growth helps to explain why value stocks could outperform growth stocks in 2021. Image: Morgan Stanley Weath Management

Cross Asset Momentum Breadth Risk-on is still strong. Are investors too optimistic? Image: Deutsche Bank Asset Allocation

Gold Price vs. U.S. 10-Year Real Rates (Using Breakeven Inflation Rate) Pictet expects gold prices to reach new highs to US$2,150/oz in the next 12 months. Image: Pictet Wealth Management

Number of S&P 500 Firms to Decrease or Suspend their Dividend Bye-bye dividends, as they have been hit hard by the coronavirus pandemic. Image: The Wall Street Journal